Evidence map›Paper›PMID 33801194›Full record

ArticleNutrients2021

Folate Levels in Patients Hospitalized with Coronavirus Disease 2019.

Eshcar Meisel, Orly Efros, Jonathan Bleier, Tal Beit Halevi, Gad Segal, Galia Rahav, Avshalom Leibowitz, Ehud Grossman

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Eshcar MeiselDepartment of Internal Medicine "D", Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel.
Orly EfrosDepartment of Internal Medicine "D", Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel.ORCID 0000-0002-6024-9110
Jonathan BleierDepartment of Internal Medicine "D", Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel.ORCID 0000-0002-0828-4867
Tal Beit HaleviDepartment of Internal Medicine "D", Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel.ORCID 0000-0003-3798-8684
Gad SegalSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.ORCID 0000-0002-3851-3245
Galia RahavSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Avshalom LeibowitzDepartment of Internal Medicine "D", Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel.
Ehud GrossmanSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Tel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to investigate the prevalence of decreased folate levels in patients hospitalized with Coronavirus Disease 2019 (COVID-19) and evaluate their outcome and the prognostic signifi-cance associated with its different levels. In this retrospective cohort study, data were obtained from the electronic medical records at the Sheba Medical Center. Folic acid levels were available in 333 out of 1020 consecutive patients diagnosed with COVID-19 infection hospitalized from January 2020 to November 2020. Thirty-eight (11.4%) of the 333 patients comprising the present study population had low folate levels. No significant difference was found in the incidence of acute kidney injury, hypoxemia, invasive ventilation, length of hospital stay, and mortality be-tween patients with decreased and normal-range folate levels. When sub-dividing the study population according to quartiles of folate levels, similar findings were observed. In conclusion, decreased serum folate levels are common among hospitalized patients with COVID-19, but there was no association between serum folate levels and clinical outcomes. Due to the important role of folate in cell metabolism and the potential pathologic impact when deficient, a follow-up of folate levels or possible supplementation should be encouraged in hospitalized COVID-19 patients. Fur-ther studies are required to assess the prevalence and consequences of folate deficiency in COVID-19 patients.

Indexed as

AgedCOVID-19FemaleFolic AcidFolic Acid DeficiencyHospitalizationHumansIsraelLength of StayMaleMiddle AgedPrognosisRetrospective StudiesRisk FactorsFolic AcidCOVID-19epidemicfolatefolate deficiencyfolic acidfolic acid deficiencyhypoxemiainvasive ventilationSARS CoV-2

Identifiers

PMID33801194
PMCPMC8001221
OpenAlexW3135138661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.